The BAI1 mAb was injected with complement to examine whether reducing the populace of Myo/Nog cells would affect cell viability. unchanged as of this early period stage in response towards the reduction in Myo/Nog cells. Nevertheless, increasing the amount of Myo/Nog cells inside the lesion by injecting BAI1-positive (+) cells Continue Reading